KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-9.16 Cr | ₹-0.88 Cr | ₹9.78 Cr | ₹-2.44 Cr | ₹9.70 Cr |
What is the latest Net Cash Inflow / Outflow ratio of KILITCH DRUGS (INDIA) ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-9.16 Cr |
| Mar2024 | ₹-0.88 Cr |
| Mar2023 | ₹9.78 Cr |
| Mar2022 | ₹-2.44 Cr |
| Mar2021 | ₹9.70 Cr |
How is Net Cash Inflow / Outflow of KILITCH DRUGS (INDIA) Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-9.16 Cr | Negative | |
| Mar2024 | ₹-0.88 Cr | Negative | |
| Mar2023 | ₹9.78 Cr | Positive | |
| Mar2022 | ₹-2.44 Cr | Negative | |
| Mar2021 | ₹9.70 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹486.3 Cr | -8.9% | -14.4% | -20% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -8.9% |
-14.4% |
-20% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses